Skip to main content
. Author manuscript; available in PMC: 2019 Apr 29.
Published in final edited form as: J Control Release. 2017 Jun 29;261:263–274. doi: 10.1016/j.jconrel.2017.06.026

Fig. 8.

Fig. 8.

Effect of PMVDS vaccination on the prevention of tumor progression. (A) Mice were administered on days 1 and 21 with PBS, ova with alum (250 μg) and ova encapsulated InAc-PMVDS. Fourteen days after the second dose, mice were challenged with a subcutaneous injection of 1 × 105 B16-ova cells. (B) Tumor volume was measured at different time intervals using the formula 0.5 × length × (width)2. (C) Percent survival of the mice is reported using Kaplan-Meier method. Data represents mean ± standard deviation (n = 8).